2026 Q2 Portfolio Activity
In 2026 Q2, Avoro Capital Advisors LLC maintained a portfolio of 35 distinct positions. The most significant new addition was ASCENDIS PHARMA, now representing 12.24% of the total fund value. They heavily accumulated shares in UNITED THERAPEUTICS CORP, increasing the position by 631.0%. Conversely, Avoro Capital Advisors LLC completely exited their position in ASCENDIS PHARMA.
Position History
hover any row below to update
Loading…
Total Positions
35
Quarter
2026 Q2
Top Holding
UTHR (13.5%)
Top 10 Concentration
79.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-35 of 35
Avoro Capital Advisors LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
UTHR
UNITED THERAPEU...
|
Healthcare | 13.52% | 15.34% |
#1
Prev: #1
|
8.0 |
—
|
147,777 | 5.6% |
P
S
|
2,777,777 | $1,505,082,912 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ASCENDIS PHARMA
|
|
Unknown | 12.24% | — |
#2
Prev: #—
|
9.0 |
—
|
5,111,111 | — |
NEW
|
5,111,111 | $1,363,235,526 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 9.64% | 7.34% |
#3
1
Prev: #4
|
5.9 |
—
|
no change | no change |
P
S
|
2,888,888 | $1,073,713,003 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 8.84% | 9.36% |
#4
1
Prev: #3
|
4.5 |
—
|
15,152 | 0.8% |
P
S
|
1,833,333 | $984,408,154 | 2018 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARGX
ARGENX SE
|
Healthcare | 8.33% | 7.18% |
#5
Prev: #5
|
4.8 |
—
|
no change | no change |
P
S
|
1,000,000 | $927,770,000 | 2017 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 8.31% | 6.60% |
#6
Prev: #6
|
5.3 |
—
|
655,556 | 6.1% |
P
S
|
11,355,555 | $925,591,288 | 2014 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 7.70% | 6.12% |
#7
Prev: #7
|
4.1 |
—
|
no change | no change |
P
S
|
7,474,747 | $857,129,238 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 3.86% | 2.24% |
#8
7
Prev: #15
|
2.0 |
—
|
-47,444 | -2.0% |
P
S
|
2,297,000 | $430,182,160 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 3.82% | 2.16% |
#9
7
Prev: #16
|
4.0 |
—
|
1,666,666 | 50.0% |
P
S
|
4,999,999 | $425,949,915 | 2016 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CELC
CELCUITY INC
|
Healthcare | 3.19% | 3.79% |
#10
Prev: #10
|
1.8 |
—
|
25,000 | 0.7% |
P
S
|
3,400,000 | $355,708,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 3.16% | 3.11% |
#11
1
Prev: #12
|
2.3 |
—
|
no change | no change |
P
S
|
6,555,555 | $351,836,637 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 3.13% | 3.31% |
#12
1
Prev: #11
|
2.3 |
—
|
no change | no change |
P
S
|
5,777,777 | $348,746,620 | 2018 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 3.04% | 0.93% |
#13
8
Prev: #21
|
3.7 |
—
|
2,188,888 | 43.8% |
P
S
|
7,188,888 | $338,165,292 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QURE
UNIQURE NV
|
Healthcare | 2.78% | 0.96% |
#14
5
Prev: #19
|
3.1 |
—
|
768,182 | 12.9% |
P
S
|
6,727,777 | $309,881,409 | 2015 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 2.21% | 2.33% |
#15
1
Prev: #14
|
1.4 |
—
|
-165,000 | -2.8% |
P
S
|
5,723,888 | $245,612,034 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 1.46% | 0.95% |
#16
4
Prev: #20
|
2.6 |
—
|
2,188,888 | 10.1% |
P
S
|
23,888,888 | $162,683,327 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 1.11% | 1.03% |
#17
Prev: #17
|
0.9 |
—
|
225,000 | 1.8% |
P
S
|
12,540,000 | $123,142,800 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GLTO
DAMORA THERAPEU...
|
Healthcare | 0.88% | 0.96% |
#18
Prev: #18
|
1.4 |
—
|
no change | no change |
P
S
|
3,783,000 | $98,395,830 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
HEMAB THERAPEUT...
|
|
Unknown | 0.63% | — |
#19
Prev: #—
|
3.8 |
—
|
1,925,150 | — |
NEW
|
1,925,150 | $70,710,760 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
GHRS
GH RESEARCH PLC
|
Healthcare | 0.43% | 0.25% |
#20
6
Prev: #26
|
1.2 |
—
|
no change | no change |
P
S
|
1,800,000 | $48,384,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.41% | 0.29% |
#21
4
Prev: #25
|
3.2 |
—
|
1,000,000 | 66.7% |
P
S
|
2,500,000 | $45,925,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SEPN
SEPTERNA INC
|
Healthcare | 0.40% | 0.32% |
#22
2
Prev: #24
|
1.2 |
—
|
no change | no change |
P
S
|
1,337,500 | $44,792,875 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.39% | 0.21% |
#23
4
Prev: #27
|
3.2 |
—
|
923,333 | 65.5% |
P
S
|
2,333,333 | $43,119,994 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SNSE
FAETH THERAPEUT...
|
Healthcare | 0.32% | — |
#24
Prev: #—
|
3.6 |
—
|
1,444,039 | — |
NEW
|
1,444,039 | $36,100,975 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
WHWK
WHITEHAWK THERA...
|
Healthcare | 0.12% | 0.10% |
#25
5
Prev: #30
|
1.0 |
—
|
no change | no change |
P
S
|
2,849,402 | $13,050,261 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LXEO
LEXEO THERAPEUT...
|
Healthcare | 0.06% | 0.11% |
#26
2
Prev: #28
|
0.0 |
—
|
-385,811 | -20.6% |
P
S
|
1,489,189 | $6,932,175 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CELC
CALL
CELCUITY INC
|
CALL Option | 0.00% | 0.03% |
Sold All 😨
(Was: #32) |
0.0 |
—
|
-200,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MNKD
MANNKIND CORP
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #31) |
0.0 |
—
|
-2,200,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UTHR
CALL
UNITED THERAPEU...
|
CALL Option | 0.00% | 0.10% |
Sold All 😨
(Was: #29) |
0.0 |
—
|
-380,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 0.00% | 0.42% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-1,200,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 0.00% | 0.76% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-2,300,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 0.00% | 2.95% |
Sold All 😨
(Was: #13) |
0.0 |
—
|
-5,695,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 0.00% | 4.47% |
Sold All 😨
(Was: #9) |
0.0 |
—
|
-11,430,455 | -100.0% |
CLOSED
|
— | $— | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
APLS
APELLIS PHARMAC...
|
Healthcare | 0.00% | 4.84% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-12,222,222 | -100.0% |
CLOSED
|
— | $— | 2017 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ASND
ASCENDIS PHARMA
|
Healthcare | 0.00% | 11.39% |
Sold All 😨
(Was: #2) |
0.0 |
—
|
-5,062,500 | -100.0% |
CLOSED
|
— | $— | 2016 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-35 of 35 holdings